GOAL STATEMENT
The goal of this activity is for learners to be better able to incorporate PGx testing into the clinical management of patients with MDD.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Demonstrate improved performance associated with [LIST][ITEM] Identifying patients with MDD who may benefit from PGx testing [ITEM]Utilizing PGx test results as a clinical guidance tool in medication selection for patients with MDD[/LIST]Demonstrate greater confidence in their ability to [LIST][ITEM] Communicate with patients regarding PGx testing[/LIST]
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
[BOLD]For Physicians[/BOLD] Medscape, LLC designates this live activity for a maximum of [bold][italic]0.50 AMA PRA Category 1 Credit(s)[/bold][/italic]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [BOLD]For Nurses[/BOLD] Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs. [BOLD]For Pharmacists[/BOLD] Medscape designates this continuing education activity for 0.50 contact hour(s) ( 0.050 CEUs) (Universal Activity Number: JA0007105-0000-24-032-L01-P).
Supported by an independent educational grant from [BOLD]Myriad Genetics[/BOLD].